Professor Limongelli took his PhD degree in Drug Sciences in 2007 and did his PostDoc at ETH Zurich (Switzerland), working in the field of enhanced sampling simulations applied to study drug/target binding interaction. In 2013 he was awarded the “Premio Scrocco” conferred by the Division of Theoretical and Computational Chemistry of the Italian Chemical Society for his original contribution to the study of biological phenomena by applying advanced computational methods. In 2016 he received the Young Researcher in Medicinal Chemistry award from the French Medicinal Chemistry Society and in 2017 the award as a most meritorious runner-up of the EFMC (the European Federation of Medicinal Chemistry) Prize for a Young Medicinal Chemist in Academia. In 2020 he was nominated top 5 scientist in physical/chemical sciences for the USERN prize. He is author of more than 70 publications, many of them on high impact scientific journals such as Nature Communications, Nature Protocols, Nature Methods, PNAS, JACS, Angewandte Chemie and Nucleic Acids Research. In 2020, he received an ERC (European Research Council) consolidator grant. More information can be found on his website.